Madrid: BACE News Roundup, Part 3
This is part 3 of our 3-part series.
6397 RESULTS
Sort By:
This is part 3 of our 3-part series.
The 10th International Conference on Alzheimer’s Disease and Related Disorders, ICAD for short, ended yesterday just outside the palatial capital of Spain...
Researchers at Harvard Medical School report that they have identified a small molecule that interferes with a protein phosphatase in such a way that...
Raging autoimmune T cells were fingered as the culprits in the toxicity of the failed first-generation Alzheimer disease (AD) vaccine. Even so...
By the wholly unscientific survey of a roving reporter, the single most convincing and surprising molecular biology story that stuck in the minds of scientists at the 10th ICAD meeting was...
Designing AD trials well would seem to be challenge enough for clinicians in the Alzheimer disease field. But even once that’s done...
Famous as they are for their powerful effects throughout the body, circulating stress hormones such as the glucocorticoid cortisol still pose somewhat of a riddle when it comes to...
This is part 1 of our 3-part series.
This is part 1 of our 3-part series.
This concludes our 3-part series.
This is part 2 of our 3-part series.
In worms, the fountain of youth is not some magical elixir, but instead springs from...
The progressive shortening of telomeres, those DNA caps that protect the ends of chromosomes, limits the lifespan of...
A paper in last Friday's Science reports that autosomal-dominant Parkinson's disease can be caused not only by α-synuclein mutations, but also by a triplication of a fragment of DNA containing the gene. This result suggests that dosage of α-synuclein...
Tomorrow's Nature magazine carries an article on head trauma that could inform parts of Alzheimer's research, as well. Esther Shohami at Hebrew University's Medical Faculty in Jerusalem, and colleagues there, report that an endogenous cannabinoid plays a role...
No filters selected